Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 268.78B | 275.24B | 254.45B | 242.29B | 226.95B | 195.93B |
Gross Profit | 34.34B | 35.35B | 32.09B | 29.70B | 27.57B | 25.25B |
EBITDA | 11.58B | 13.40B | 12.15B | 11.14B | 10.28B | 8.92B |
Net Income | 7.84B | 8.10B | 7.37B | 6.29B | 5.84B | 5.01B |
Balance Sheet | ||||||
Total Assets | 75.48B | 77.10B | 69.83B | 68.99B | 64.17B | 59.27B |
Cash, Cash Equivalents and Short-Term Investments | 14.85B | 15.28B | 11.14B | 15.23B | 11.05B | 12.18B |
Total Debt | 8.18B | 8.17B | 8.27B | 8.88B | 9.04B | 10.13B |
Total Liabilities | 48.36B | 47.94B | 46.21B | 43.94B | 43.52B | 41.19B |
Stockholders Equity | 27.13B | 29.16B | 23.62B | 25.06B | 20.64B | 17.56B |
Cash Flow | ||||||
Free Cash Flow | 7.32B | 7.84B | 6.63B | 6.75B | 3.50B | 5.37B |
Operating Cash Flow | 12.43B | 13.34B | 11.34B | 11.07B | 7.39B | 8.96B |
Investing Cash Flow | -5.05B | -5.31B | -4.41B | -4.97B | -3.92B | -3.54B |
Financing Cash Flow | -4.00B | -3.77B | -10.76B | -2.61B | -4.28B | -6.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $419.21B | 53.62 | 30.69% | 0.52% | 8.17% | 9.92% | |
75 Outperform | 822.48B | 38.88 | 23.69% | 0.88% | 4.23% | 38.05% | |
72 Outperform | 39.92B | 10.16 | 25.47% | 5.12% | -1.55% | -11.41% | |
68 Neutral | 22.48B | 19.03 | 14.87% | 2.31% | 4.98% | -15.98% | |
66 Neutral | 12.27B | 21.38 | 27.58% | ― | 2.48% | 9.41% | |
53 Neutral | 19.39B | -7.00 | -82.21% | ― | -29.67% | -178.03% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |